5-Star Stocks Poised to Pop: PerkinElmer
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, health and industrial sciences company PerkinElmer (NYS: PKI) has earned a coveted five-star ranking.
With that in mind, let's take a closer look at PerkinElmer's business and see what CAPS investors are saying about the stock right now.
|Headquarters (Founded)||Waltham, Mass. (1931)|
|Market Cap||$2.18 billion|
|Industry||Life sciences tools and services|
|Trailing-12-Month Revenue||$1.82 billion|
Chairman/CEO Robert Friel
Vice President/CFO Frank Wilson
|Return on Equity (Average, Past 3 Years)||6.8%|
|Cash/Debt||$395.2 million / $671 million|
Agilent Technologies (NYS: A)
Thermo Fisher Scientific (NYS: TMO)
Waters (NYS: WAT)
Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.
Earlier this month, Clint35 succinctly summed up the PerkinElmer bull case: "Looks very cheap. Plus a small dividend."
In fact, PerkinElmer currently sports a particularly cheap P/E of 6.3. That represents a clear discount to rivals Agilent (11.1), Thermo Fisher (15.1), and Waters (16.8).
CAPS member Tradersinfo elaborated on the bargain opportunity back in June:
BUY $30.00 price target. ParkinElmner is a rebound-story. The Company has gone through no less than two restructuring programs in the last 12 months, both of which have been successful in reducing costs. Profit margin has improved to 13.6%, while the earnings forecast is also in the double-digit range (incidentally, 13.5%). ... [R]elatively fast growth momentum coupled with favorable valuation and, of course (how could I forget?) low beta. Favorable risk/reward in sum.
What do you think about PerkinElmer, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!
Interested in another easy way to trackPerkinElmer?Add it to your watchlist.
At the time this article was published Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Motley Fool newsletter services have recommended buying shares of Thermo Fisher. Try any of our Foolish newsletter services free for 30 days.We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.
Copyright © 1995 - 2011 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.